Stemmer Imaging AG

XTRA:S9I Voorraadrapport

Marktkapitalisatie: €349.7m

Stemmer Imaging Toekomstige groei

Future criteriumcontroles 5/6

Stemmer Imaging zal naar verwachting groeien in winst en omzet met respectievelijk 27.6% en 9.4% per jaar. De winst per aandeel zal naar verwachting groeien met 19.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 21.4% zijn.

Belangrijke informatie

27.6%

Groei van de winst

19.6%

Groei van de winst per aandeel

Electronic winstgroei39.7%
Inkomstengroei9.4%
Toekomstig rendement op eigen vermogen21.4%
Dekking van analisten

Low

Laatst bijgewerkt14 Nov 2024

Recente toekomstige groei-updates

Recent updates

Is Stemmer Imaging (ETR:S9I) Using Too Much Debt?

Jul 23
Is Stemmer Imaging (ETR:S9I) Using Too Much Debt?

Stemmer Imaging AG (ETR:S9I) Screens Well But There Might Be A Catch

Jun 22
Stemmer Imaging AG (ETR:S9I) Screens Well But There Might Be A Catch

Stemmer Imaging's (ETR:S9I) Conservative Accounting Might Explain Soft Earnings

May 21
Stemmer Imaging's (ETR:S9I) Conservative Accounting Might Explain Soft Earnings

Stemmer Imaging (ETR:S9I) Is Achieving High Returns On Its Capital

Jan 27
Stemmer Imaging (ETR:S9I) Is Achieving High Returns On Its Capital

Should You Be Adding Stemmer Imaging (ETR:S9I) To Your Watchlist Today?

Nov 02
Should You Be Adding Stemmer Imaging (ETR:S9I) To Your Watchlist Today?

Under The Bonnet, Stemmer Imaging's (ETR:S9I) Returns Look Impressive

Sep 27
Under The Bonnet, Stemmer Imaging's (ETR:S9I) Returns Look Impressive

Stemmer Imaging (ETR:S9I) Will Pay A Larger Dividend Than Last Year At €3.00

Mar 09
Stemmer Imaging (ETR:S9I) Will Pay A Larger Dividend Than Last Year At €3.00

Stemmer Imaging (ETR:S9I) Has A Rock Solid Balance Sheet

Nov 04
Stemmer Imaging (ETR:S9I) Has A Rock Solid Balance Sheet

Returns On Capital At Stemmer Imaging (ETR:S9I) Have Hit The Brakes

Jul 23
Returns On Capital At Stemmer Imaging (ETR:S9I) Have Hit The Brakes

Is There Now An Opportunity In Stemmer Imaging AG (ETR:S9I)?

Jun 28
Is There Now An Opportunity In Stemmer Imaging AG (ETR:S9I)?

Is Stemmer Imaging AG (ETR:S9I) Potentially Undervalued?

Jan 20
Is Stemmer Imaging AG (ETR:S9I) Potentially Undervalued?

Stemmer Imaging (ETR:S9I) Seems To Use Debt Quite Sensibly

Dec 11
Stemmer Imaging (ETR:S9I) Seems To Use Debt Quite Sensibly

Are Stemmer Imaging AG (ETR:S9I) Investors Paying Above The Intrinsic Value?

Jul 21
Are Stemmer Imaging AG (ETR:S9I) Investors Paying Above The Intrinsic Value?

Stemmer Imaging (ETR:S9I) Will Will Want To Turn Around Its Return Trends

May 10
Stemmer Imaging (ETR:S9I) Will Will Want To Turn Around Its Return Trends

Here's What Analysts Are Forecasting For Stemmer Imaging AG (ETR:S9I) After Its Full-Year Results

Mar 27
Here's What Analysts Are Forecasting For Stemmer Imaging AG (ETR:S9I) After Its Full-Year Results

An Intrinsic Calculation For Stemmer Imaging AG (ETR:S9I) Suggests It's 23% Undervalued

Mar 18
An Intrinsic Calculation For Stemmer Imaging AG (ETR:S9I) Suggests It's 23% Undervalued

Does Stemmer Imaging AG (ETR:S9I) Have A Place In Your Dividend Stock Portfolio?

Feb 24
Does Stemmer Imaging AG (ETR:S9I) Have A Place In Your Dividend Stock Portfolio?

What Is The Ownership Structure Like For Stemmer Imaging AG (ETR:S9I)?

Feb 04
What Is The Ownership Structure Like For Stemmer Imaging AG (ETR:S9I)?

Health Check: How Prudently Does Stemmer Imaging (ETR:S9I) Use Debt?

Jan 05
Health Check: How Prudently Does Stemmer Imaging (ETR:S9I) Use Debt?

Are Investors Undervaluing Stemmer Imaging AG (ETR:S9I) By 43%?

Dec 15
Are Investors Undervaluing Stemmer Imaging AG (ETR:S9I) By 43%?

Winst- en omzetgroeiprognoses

XTRA:S9I - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261842018214
12/31/20251601615174
12/31/2024139517184
6/30/2024126122728N/A
3/31/2024133132324N/A
12/31/2023146161920N/A
9/30/2023155182123N/A
6/30/2023161201820N/A
3/31/2023160191820N/A
12/31/2022155181516N/A
9/30/20221451589N/A
6/30/20221391399N/A
3/31/20221351299N/A
12/31/20211301088N/A
9/30/202112491111N/A
6/30/2021115699N/A
3/31/2021105-11011N/A
12/31/2020103-31011N/A
9/30/2020109-846N/A
6/30/2020115-746N/A
3/31/2020121-168N/A
12/31/2019121113N/A
9/30/2019116535N/A
6/30/2019109445N/A
3/31/2019106201N/A
12/31/2018104223N/A
9/30/20181026N/AN/AN/A
6/30/2018101623N/A
3/31/2018984N/AN/AN/A
12/31/2017944N/A8N/A
9/30/2017903N/AN/AN/A
6/30/2017883N/A5N/A
6/30/2016842N/A5N/A
6/30/2015762N/A2N/A
6/30/2014653N/A5N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei S9I ( 27.6% per jaar) ligt boven de spaarquote ( 1% ).

Winst versus markt: De winst van S9I ( 27.6% per jaar) zal naar verwachting sneller groeien dan de German markt ( 20.8% per jaar).

Hoge groeiwinsten: De winst van S9I zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van S9I ( 9.4% per jaar) zal naar verwachting sneller groeien dan de markt German ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van S9I ( 9.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen S9I zal naar verwachting over 3 jaar hoog zijn ( 21.4 %)


Ontdek groeibedrijven